Skip to main content

Cornell University

CIW REPORTS

Comments and Content from Cornell in Washington

Breaking Down the FTC’s Crackdown on Healthcare Conglomerates

Breaking Down the FTC’s Crackdown on Healthcare Conglomerates

The Federal Trade Commission (FTC) is taking a bold step to address the increasing concentration in the U.S. healthcare market. In a recent speech, FTC Chair Lina Khan emphasized the agency’s focus on private equity acquisitions of healthcare service providers, including outpatient clinics, nursing homes, and physician practices. She stated, “So much has changed in the provision of health care over the past several decades. One area that is top of mind for the FTC is private equity acquisitions of health care service providers such as outpatient clinics, nursing homes, and physician practices. In recent years, these private investments have soared.”

When the healthcare market lacks competition, consumers and small providers suffer, while conglomerates reap soaring profits. Market concentration stifles competition, which is crucial for the healthcare industry as it directly impacts consumer welfare—their health. The FTC regulates concentration in the healthcare market by monitoring mergers and acquisitions and filing suits against anti-competitive practices. However, the commission has struggled to prevent conglomerates from growing at unprecedented rates in recent decades.

FTC Chair Lina Khan addressing the issue of healthcare market concentration.

The Impact of Healthcare Market Concentration

The concentration of the U.S. healthcare system has left millions of Americans with unaffordable care and decreased quality of service. Preventing mergers and acquisitions that hinder competition relies heavily on antitrust law. Unfortunately, antitrust law has been insufficient in mitigating the intense concentration of healthcare companies, particularly hospitals. From 2000 to 2020, there were over 1,000 hospital mergers, yet the FTC only took 13 enforcement actions against these mergers.

Healthcare prices have surged more than in any other sector since 2000, affecting services, medical devices, and pharmaceutical products. Most consumers do not directly pay for these rising costs due to the complexities of the healthcare market, where the majority of working-age adults are insured through employer-sponsored health insurance (ESI). Currently, 54.3% of the U.S. population and 63% of adults under age 65 have ESI coverage. ESI is funded out of employees’ wages, creating a direct link between employee wages and rising healthcare costs. As healthcare prices climb, so do ESI premiums, leading to decreased labor demand and lower employment rates.

Visual representation of healthcare market concentration and its effects.

The Consequences of Market Concentration

Market concentration in healthcare can lead to higher prices and premiums. In concentrated markets, hospitals can negotiate higher prices without improving the quality of care, resulting in increased spending and a negative impact on individuals’ ability to afford care. In insurance markets, high concentration can diminish competition among insurers, leading to higher premiums.

Antitrust laws are meant to prevent mergers and acquisitions that stifle competition in the healthcare market. However, their effectiveness has been limited. Research by Brot-Goldberg et al. indicates that between 2010-2015, 304 horizontally merged hospitals raised inpatient and outpatient prices by 2.6% and 1.0%, respectively, within two years of the transaction. This averages to a 1.2% increase in prices post-merger. Another study published in Health Services Research found that cross-market mergers led to a nearly 13% increase in healthcare prices over six years, with price hikes even higher—21.8%—when the acquired hospital had a larger market share than the acquiring hospital.

The trend of hospital mergers contributing to rising healthcare costs.

The Broader Implications of Rising Healthcare Prices

The effects of increased healthcare prices extend beyond the healthcare sector. A 1% increase in healthcare prices can lower payroll and employment at firms outside the healthcare industry by approximately 0.4%, and reduce per capita labor income by 0.27%. Moreover, rising healthcare costs correlate with a 2.7% increase in deaths from suicide and overdoses among individuals who can no longer afford healthcare, known as “deaths of despair.” Alarmingly, 1 in 140 people who lose their jobs due to rising healthcare costs dies from such deaths of despair.

The Human Toll of Healthcare Consolidation

The human toll of healthcare consolidation is profound and multifaceted. For many Americans, healthcare costs have become a burden that affects all aspects of life. High healthcare costs can lead to delayed or foregone care, resulting in worsened health outcomes and higher long-term costs for both individuals and the system. Studies have shown that individuals in highly concentrated healthcare markets face not only higher costs but also reduced access to care, leading to worse health outcomes overall.

For small healthcare providers, the rise of large conglomerates often means being forced out of the market or being bought out at lower valuations. This diminishes the diversity of care options available to consumers and can lead to a one-size-fits-all approach to healthcare delivery, which is often less effective in meeting the unique needs of different populations.

Small healthcare providers struggling against large conglomerates.

Policy Recommendations and Future Directions

To address these challenges, the FTC and other regulatory bodies must take a multifaceted approach. Strengthening antitrust enforcement is a critical step, but it must be complemented by other measures to enhance market competition. This includes promoting transparency in healthcare pricing, encouraging the development of alternative care models such as accountable care organizations (ACOs), and supporting state-level initiatives to regulate healthcare costs.

Moreover, there is a need for legislative reforms to empower the FTC and other regulatory agencies with greater authority and resources to tackle the complexities of healthcare market concentration. Enhanced data collection and analysis capabilities can also help regulators better understand market dynamics and identify anti-competitive behaviors more effectively.

The Federal Trade Commission building, where significant decisions affecting the healthcare market are made.

The Path Forward

Given the significant implications of healthcare market concentration, the FTC’s renewed focus on regulating mergers and acquisitions in the sector is a crucial step towards ensuring affordable and high-quality healthcare for all Americans. Chair Lina Khan’s commitment to addressing these issues is a promising development in the ongoing battle against healthcare conglomerates’ market power.

By taking stringent actions against anti-competitive mergers, the FTC aims to foster a more competitive healthcare market, which is essential for improving consumer welfare. Ensuring competition in the healthcare sector is not just about economic principles; it’s about safeguarding the health and well-being of millions of Americans.

As the FTC intensifies its efforts to dismantle healthcare conglomerates, it is crucial for policymakers, healthcare providers, and the public to support these initiatives. The future of America’s healthcare system depends on maintaining a competitive market that prioritizes the health of its citizens over the profits of a few large corporations.

In conclusion, the FTC’s crackdown on healthcare conglomerates is a significant step towards restoring competition in the healthcare market. While the path forward will require robust enforcement and comprehensive policy measures, the potential benefits in terms of affordability, accessibility, and quality of care make this a critical initiative. The health and economic well-being of millions of Americans depend on the success of these efforts.

Suggestions for further reading: